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Purpose: This retrospective review describes the surgical management of renovascular disease in 25 consecutive children
and adolescents with severe hypertension.
Methods: Patients <21 years of age (mean age, 11.6  5.4 years; 12 females, 13 males) underwent repair of 34 renal
arteries (RAs), and their management forms the basis of this report. Early and late blood pressure responses were adjusted
for gender, age, and height. RA repair was evaluated by angiography, renal duplex sonography (RDS) scanning, or both.
Primary patency and survival were estimated by product-limit methods.
Results: Thirty-four RAs among 32 kidneys were repaired. Bilateral renal RA disease to a solitary kidney was present in
nine patients. RA lesions included dysplasia (44%), RA hypoplasia (20%), midaortic syndrome (12%), RA aneurysm
(12%), dissection (8%), and arteritis (4%). All patients had severe hypertension (>95th percentile systolic or diastolic
pressure adjusted for gender, age, and height). RA repair comprised 25 bypasses (73%) consisting of 28% saphenous vein,
60% hypogastric artery, and 12% polytetrafluoroethylene; 2 patch angioplasties (6%), and 7 reimplantations (21%).
Branch RA exposure was required in 28 kidneys (88%), and branch reconstruction was required in 61%. Warm in situ
repair was used in 53%, in situ cold perfusion in 24%, and ex vivo cold perfusion in 23%. Of six bilateral RA repairs, one
was staged and two patients are awaiting a staged repair. Combined aortic reconstruction was required in three patients.
No unplanned nephrectomy was performed. There were no perioperative deaths. Hypertension was cured in 36%,
improved in 56%, and failed in 8% at mean follow-up of 46.4  7.8 months. The mean calculated glomerular filtration
rate increased from 82.0 mL/min/1.73 m2 preoperatively to 98.2 mL/min/1.73 m2 postoperatively. The postoperative
patency of 30 RA reconstructions was evaluated by angiography, RDS scanning, or both. At mean follow-up of 32.8
months (median, 21.2 months), primary RA patency was 91%. No failures were observed after 2 months follow-up.
Estimated survival was 100% at 60 months, with one death 9 years after surgery.
Conclusions: Renovascular hypertension in children and adolescents was caused by a heterogeneous group of lesions. All
patients had RA repair, with arterial autografts in most of the RA bypasses. Cold perfusion preservation was used in half
of the complex branch RA repairs. These strategies provided 91% primary patency at mean follow-up of 32.8 months,
with beneficial blood pressure response in 92%. Surgical repair of clinically significant renovascular disease in children and
adolescents is supported by these results. ( J Vasc Surg 2005;41:973-82.)The prevalence of hypertension in children and adoles-
cents is much lower than adults.1,2 In adults, primary or
essential hypertension accounts for90% of elevated blood
pressure. In children, however, secondary or correctible
causes of hypertension account for a much higher propor-
tion.3,4 In general, the more severe the hypertension and
the younger the child, the greater the likelihood that a
secondary cause exists.1,2,5 Consequently, the evaluation of
the child with severe hypertension must include a thorough
search for a correctible cause.
With the exception of neonates and children1 year of
age in whom aortic coarctation is the leading cause of
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doi:10.1016/j.jvs.2005.03.007hypertension, lesions of the renal arteries (RAs) represent
the most common correctible cause of severe hypertension
in the pediatric population.6 RA lesions share a renin-
angiotensin mechanism of secondary hypertension; how-
ever, the lesions themselves are heterogeneous.7 Despite
important differences, the essential requirements for RA
repair are the same—lifelong durability with preservation of
renal function.
This retrospective review describes our center’s surgical
management of renovascular disease in children and ado-
lescents with severe hypertension. The specific objectives of
this review are to (1) describe the variety of RA lesions
contributing to secondary hypertension, (2) describe the
strategies of evaluation and operative management and (3)
estimate the primary patency and blood pressure response
associated with these strategies.
METHODS
From January 1987 through May 2004, 832 patients
had operative RA repair at Wake Forest University School
of Medicine/North Carolina Baptist Medical Center. Hos-
pital records of the subgroup of patients 21 years of age
treated for RA disease were reviewed from an investiga-
tional review board-approved vascular registry. Children
with disease of transplanted kidneys were excluded. Etiol-
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angiographic evaluation and confirmed by surgical and
pathologic examination.
Last follow-up and ambulatory blood pressure mea-
surements were obtained from clinical records. Severe pre-
and postoperative hypertension was defined as systolic or
diastolic blood pressure values exceeding the 95th percen-
tile for gender, age, and height as described by the Update
on the 1987 Task Force Report on High Blood Pressure in
Children and Adolescents.8
Postoperative assessment of repair was made clinically by
angiography, renal duplex sonography (RDS) scanning, or
both. Data obtained at the initial preoperative clinic visit and
at the last postoperative follow-up were used in the analysis.
For patients no longer followed at this institution, data were
obtained by telephone contact with the patients’ physicians.
Table I. Patient characteristics at presentation
Pt Age (yrs) Gender Diagnosis
1 1 M Hypoplasia
2 5 F Dysplasia
3 5 F Aneurysm
4 6 F Dysplasia
5 6 M Dysplasia
6 6 F Dissection
7 7 M Dysplasia
8 7 F MAS
9 10 M Dissection
0 10 F Dysplasia
1 10 F Aneurysm
2 11 F Hypoplasia
3 11 M Hypoplasia
4 11 M Dysplasia
5 11 F Dysplasia
6 12 F Dysplasia
7 13 F MAS
8 14 M Arteritis
9 15 M Dysplasia
0 16 M Dysplasia
1 18 M Aneurysm
2 19 M MAS
3 20 F Dysplasia
4 21 M Hypoplasia
5 21 M Hypoplasia
SBP, Systolic blood pressure; DBP, diastolic blood pressure; RA, renal arte
*95th percentile for SBP or DBP hypertension based or gender, age, and h
Table II. Preoperative and postoperative blood pressures
Outcome N
Gender
M:F
Preoperative means  SE
Age (yrs) BP
Cured 9 5:4 10.2  1.4 183  16.0/101  7.7
Improved 14 6:8 12.7  1.5 186  8.5/111  6.1
Failed 2 2:0 14.5  7.4 179  31.5/98  2.5
All Patients 25 13:12 11.6  5.4 185  7.5/107  4.5
BP, Blood pressure.
*P .01 from preoperative means.Mortality data were obtained from clinical follow-up and aNational Death Index search. Patency rates and patient sur-
vival were estimated by the product-limit method.
Hypertension response to operation was determined by
blood pressure and antihypertensive medication require-
ments at last follow-up. The hypertension response was
defined as:
● Cured—systolic and diastolic blood pressure 95th
percentile for gender, age, and height without antihy-
pertensive medications;
● Improved—systolic and diastolic blood pressures
95th percentile while the patient is on the same (or
fewer) number of antihypertensive agents, or diastolic
blood pressures 15% lower than preoperative levels;
● Failed—Severe hypertension on antihypertensive
agents and15% reduction in diastolic pressures com-
Pre-op BP
95th Percentile
SBP/DBP*
Pre-op # BP
Meds
150/90 109/63 4
220/110 108/71 3
220/130 112/72 2
175/109 112/73 1
152/77 115/76 1
120/80 116/76 0
147/95 119/78 1
156/82 115/76 2
220/126 115/78 2
145/110 120/79 3
180/110 122/80 3
151/105 118/78 1
128/78 121/80 1
214/140 123/81 3
200/110 124/81 4
210/125 125/82 1
260/110 126/82 1
139/66 128/82 1
200/100 129/83 3
220/140 129/83 2
180/110 138/88 1
180/110 140/89 2
240/160 132/86 2
200/90 138/88 1
210/100 132/85 5
S, midaortic syndrome.
8
Postoperative means  SE
BP Meds Age( yrs) BP # BP Meds
 0.34 15.3  2.2 107  5.3/67  3.7* 0
 0.29 14.9  1.6 128  3.0/75  3.1* 0.93  0.20*
 2.0 21.0  9.2 159  1.5/110  20.5 2.0  1.0
 0.24 15.0  1.3 123  3.8/75  3.3* 0.68  0.17*#
1.6
2.1
3.0
2.0pared with preoperative levels.
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Volume 41, Number 6 Piercy et al 975The glomerular filtration rate (GFR) before and after
operation was estimated from a prediction equation for
children (Counahan-Barratt equation).9 A 20% change in
the postoperative calculated GFR was considered signifi-
cant. Postoperative heights were estimated from the pa-
tient’s percentile height at presentation adjusted for age at
the time of last serum creatinine measurement.
RESULTS
The study included 25 children and adolescents 21
years of age (mean  SE, 11.6  5.4 years; range, 18
months to 21 years) and included 12 females and 13 males.
Fig 1. A, A focal right renal artery stenosis in an 11
commonly considered dysplastic, this lesion in childhood
intraoperative “hourglass” deformity.
Fig 2. A, B, Aortography and right renal arteriography
demonstrating a left renal artery (RA) aneurysm with n
demonstrated branch left RA occlusion and interval developmSevere hypertension (95th percentile of blood pressure
adjusted for gender, age, and height) was present in all
patients preoperatively (mean blood pressure, 185  7.5
/107  4.5 mm Hg; mean antihypertensive agents, 2.0 
0.24) (Tables I and II). Thirteen patients (52%) had symp-
toms or sequela of severe hypertension at presentation.
Three patients had seizures (new onset in two), 1 patient
had a cerebrovascular accident, 7 patients demonstrated left
ventricular hypertrophy on echocardiography, electrocar-
diogram (ECG), chest radiograph, or both, 1 patient dem-
onstrated right ventricular hypertrophy on echocardiogra-
phy, and 2 patients had ECG changes, dysrhythmias, or
old boy with severe hypertension. B, Although most
quently developmental or hypoplastic, demonstrating an
8-year-old boy with an arteritis of unknown etiology10
l right RA. C, Repeat renal arteriography 5 years later-year-
is frein an
ormaent of a 4.5 cm right RA aneurysm.
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mL/min/1.73 m2 (Counahan-Barratt equation),9 and one
patient presented with postprandial abdominal pain associ-
ated with combined visceral artery disease.
All patients were studied with digital or cut film angiog-
raphy. Bilateral RA disease or disease to a solitary kidney
was present in nine patients (36%). RA lesions included
Fig 3. A, Midaortic syndrome in a 7-year-old girl with
RA. B, These lesions coexisted in combination with
compensated by a larger meandering mesenteric artery
Fig 4. The focal main right renal artery stenosis of intimal fibro-
plasia in an 11-year-old girl.dysplasia (44%), RA hypoplasia (20%), midaortic syndrome(12%), RA aneurysm (12%), dissection (8%), and an arteritis
of unknown etiology10 (4%) (Table I and Figs 1 to 4).
Eleven patients had preoperative RDS scans. Nine (69%) of
13 RA lesions were detected with these studies. RDS scans
failed to detect accessory left RAs in two patients and left
RA aneurysms in two patients. Thirty-four RAs were re-
paired in 32 kidneys and these repairs are summarized in
Table III. Twenty-five RA bypasses were performed (73%)
using saphenous vein (28%), hypogastric artery (60%), or
polytetrafluoroethylene (PTFE) grafts (12%). Two RAs
were repaired with patch angioplasties (6%), and seven RA
reimplantations (21%) were performed. Branch RA expo-
sure was required in 28 kidneys (88%), and branch recon-
struction was required in 61%. Warm in situ repair was done
in 53%, in situ cold perfusion in 24%, and ex vivo cold
perfusion (23%) (Table III). Excision of tissue consistent
with renal agenesis was performed in one patient.
Of six bilateral RA repairs, one was staged. Two patients
with bilateral RA disease are awaiting a contralateral RA repair.
Combined aortic reconstruction was required in three patients
(12%) with midaortic syndrome by patch aortoplasty, aor-
toaortic bypass, or aortobilateral iliac bypass.
There were no perioperative deaths. Mean length of
hospital stay was 9  0.74 days (Table III). Morbidity
extending hospital stay was observed in two patients (8%).
A postoperative ileus developed in one patient, and another
patient had early thrombosis of a left RA repair treated with
nephrectomy.
At mean follow-up of 46.4  7.8 months (range, 1 to
140 months), hypertension was cured in 36%, improved in
56%, and unchanged in 8%. Considering all patients, the
ial stenoses of two left renal arteries (RAs) and one right
sion of the celiac axis and superior mesenteric arteryorific
occlumean postoperative blood pressure (123  3.8/75  3.3
ein.
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(0.68  0.17 antihypertensive agents) were significantly
reduced from preoperative values (P.01) (Table II).
From the calculated GFR, 48% had improvement, 48%
had no change, and 4% had worsened renal function. For
the entire group, mean calculated GFR increased from 82.0
mL/min/1.73 m2 preoperatively to 98.2 mL/min/1.73
Table III. Surgical management
PT
Age
(yrs) Gender Diagnosis Treatment
1 1 M Hypoplasia Bil branch RA bypasses Hy
2 5 F Dysplasia Bil RA bypasses Hy
3 5 F Aneurysm L RA bypass Hy
4 6 F Dysplasia R RA bypass, L RA
angioplasty
Hy
5 6 M Dysplasia L RA reimplantation L R
6 6 F Dissection L RA bypass Hy
7 7 M Dysplasia L RA branch
reimplantation
L R
8 7 F MAS Aortoaortic bypass, 2
L RA
reimplantations
2 L
9 10 M Dissection L RA bypass Hy
10 10 F Dyspalsia L RA in situ cold
perfusion
Hy
11 10 F Aneurysm Staged branch R RA
bypass & L RA ex
vivo reconstruction
Re
H
12 11 F Hypoplasia Branch R RA bypass Hy
13 11 M Hypoplasia R RA bypass PT
14 11 M Dyspalsia L RA ex vivo
reconstruction
Hy
15 11 F Dyspalsia R RA bypass, L
nephrectomy
Hy
16 12 F Dyspalsia L RA bypass Hy
17 13 F MAS Aorto-Bil iliac bypass,
R RA bypass, 2 L
RA reimplantations
PT
D
18 14 M Arteritis R RA ex vivo
reconstruction of
planned staged
repairs
PT
19 15 M Dyspalsia R RA in situ cold
perfusion
Re
20 16 M Dyspalsia R RA ex vivo
reconstruction
Hy
21 18 M Aneurysm L RA in situ cold
perfusion
Re
22 19 M MAS AA patch angioplasty,
R RA
reimplantation,
L RA
aneurysmectomy &
angioplasty
R R
23 20 F Dysplasia L RA in situ cold
perfusion of planned
staged repairs
Re
24 21 M Hypoplasia Bil RA bypasses Re
25 21 M Hypoplasia L RA bypass Re
LOS, Length of stay; BP, blood pressure; RA, renal artery; Bil, bilatera
polytetrafluoroethylene.
*Thrombosed by postoperative day 9, required L nephrectomy.
†Stenosed by postoperative day 25, required RRA bypass with saphenous vm2 postoperatively (paired t test, P.05). No patient hadprogressed to dialysis dependence on follow-up. Neither
blood pressure nor renal function response was adversely
affected by the requirement for branch RA repair.
Postoperative patency of 30 RA reconstructions (88%)
was evaluated by either angiography (13%), RDS scanning
(50%), or by both methods (37%). Following a 1993 valid-
ity analysis of intraoperative RDS that allows immediate
onduit
LOS
(days)
Follow-up
(months)
Outcome
(repair)
Response
(BP)
stric artery 8 20.0 Patent Improved
stric artery 13 — Patent Cured
stric artery 13 2.9 Patent Improved
stric artery 10 84.7 Patent Improved
9 17.6 Patent Cured
stric artery 10 140.6 Patent Cured
9 57.3 Patent Failed
to Dacron 10 23.9 Patent Cured
stric artery 10 — Patent Cured
stric artery 6 74.7 Patent Improved
enous vein,
gastric artery
6 & 5 22.5 Patent Improved
stric artery 9 34.1 Patent Improved
5 67.7 Patent Cured
stric artery 21 0.7 Thrombosis* Cured
stric artery 7 24.0 Patent Improved
stric artery 8 — Patent Improved
implant to
n
13 81.6 Patent Cured
7 15.5 Patent Improved
enous vein 7 97.2 Patent Improved
stric artery 8 33.3 Patent Improved
enous vein 6 7.1 Patent Cured
tch to L 16 5.7 Stenosis† Improved
enous vein 8 15.7 Patent Improved
enous vein 10 — Patent Improved
enous vein 6 101.2 Patent Failed
right; L, left; MAS, midaortic syndrome; AA, abdominal aorta; PTFE,C
poga
poga
poga
poga
A
poga
A
RA
poga
poga
v saph
ypo
poga
FE
poga
poga
poga
FE re
acro
FE
v saph
poga
v saph
A pa
v saph
v saph
v saph
l; R,revision of repair, each reconstruction has been studied at
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each repair was carefully noted to facilitate complete post-
operative duplex interrogation on follow-up. Anatomic
evaluation at 32.8 months (median, 21.2 months) revealed
a 91% product-limit estimate of primary patency for 30 RA
bypasses among 22 patients (Figure 5).
Two early failures of RA repair occurred. Postoperative
thrombosis of a left RA hypogastric artery ex vivo recon-
struction required a left nephrectomy. This patient was
cured of hypertension. A right RA reimplantation that had
been combined with an aortic patch angioplasty and left RA
aneurysmectomy for midaortic syndrome demonstrated
right RA stenosis at postoperative day 25. This patient had
an improved hypertension response after revision with a
saphenous vein bypass graft. No failures were observed in
21 RAs evaluated after 2 months of follow-up. Estimated
survival was 100% at 60 months. One death occurred 9
years after surgery.
DISCUSSION
This retrospective report reviewed operative manage-
ment of renovascular hypertension in children and adoles-
cents, which emphasized revascularization for a heteroge-
neous group of RA lesions. Five different lesions of the RA
were observed in these 25 patients. Branch RA exposure
was required in most, and branch renal reconstruction was
performed in half. Primary nephrectomy was performed
only for renal agenesis and nonfunction combined with a
contralateral renal artery repair.
In adults, RDS scanning is our center’s screening study
of choice for renovascular disease contributing to hyperten-
sion and renal insufficiency (ie, ischemic nephropathy).12
Fig 5. Product-limit estimates of renal artery repair primary pa-
tency (n  30 renal arteries).When a duplex scan is obtained to evaluate renal insuffi-ciency, a negative result excludes ischemic nephropa-
thy.13,14 However, renal duplex scanning does not define
multiple polar RAs or branch RA disease.12 This feature has
particular significance in the child and adolescent, where
branch RA disease accounted for 50% of repaired lesions. In
this series, only 9 of 13 RDS studies defined significant RA
disease. Consequently, we continue to rely on aortography
and renal arteriography to evaluate severe hypertension in
children. Aortography with lateral and oblique views was
obtained in all patients; however, selective renal angiogra-
phy was reserved for children 5 years of age.
Management of unilateral renovascular disease in an
adult is frequently guided by the results of renal vein renin
assays.15,16 However, renal vein renin assays are rarely
obtained in the child with severe hypertension in combina-
tion with severe RA lesions. Empiric RA repair in this
instance presumes that the incidence of severe essential
hypertension in the child and adolescent is essentially nil.
Moreover, empiric repair in the child assumes minimal
mortality risk, with a high rate of beneficial blood pressure
response. The current series supports these latter assump-
tions—there were no perioperative deaths and a beneficial
blood pressure response was observed in 92% of patients.
Once a severe RA lesion is defined in a child with severe
hypertension, the timing of repair should be considered. In
this series, surgical repair was delayed in infants until 4 or 5
years of age. At this age, the size of the RA approaches that
of an adult, favoring long-term patency of repair. However,
a delay in repair presumes that hypertension can be brought
under satisfactory control with medication. If hypertension
is uncontrolled, especially when severe hypertension is
symptomatic, the RA lesion is repaired regardless of age. In
this regard, one child was operated on at 18 months of age,
when blood pressure remained severe and symptomatic
despite medication.
Other features of current surgical management deserve
comment. Current management strives to correct all he-
modynamically significant renovascular disease at a single
operation.17-19 However, complex branch RA disease re-
quiring bilateral ex vivo repair is treated in staged fash-
ion.4,20 Provided blood pressure is brought under control
with medication after unilateral RA reconstruction, the
second ex vivo procedure is performed 6 to 12 months after
the first. Moreover, indirect or splanchnorenal reconstruc-
tion is not recommended for children.3,21,22 Although
asymptomatic in most cases, visceral artery stenosis often
accompanies hypoplastic or developmental RA lesions.18
Finally, the hemodynamics of RA blood flow in child-
hood place special requirements on the choice of conduit
for aortorenal bypass.23 When the entirety of the kidney is
reconstructed at a branch level, a hypogastric artery au-
tograft is preferred. Normal arterial autograft placed with-
out technical error should provide lifelong patency.18,24
However, views of the pelvic circulation should be included
during preoperative aortography and the absence of hypo-
gastric artery disease confirmed at surgery. In this latter
regard, one child demonstrated dysplastic hypogastric ar-
teries, and another demonstrated hypogastric artery aneu-
JOURNAL OF VASCULAR SURGERY
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duits. PTFE was used for reconstruction in these patients
and in an additional patient who had hypogastric arteries of
insufficient length for the RA bypass.
The liabilities of saphenous vein as an aortorenal graft
in children have been noted by a number of authors.23,25,26
Enlargement and aneurysmal change of vein grafts in chil-
dren have been attributed to differences in the intrinsic
blood supply of immature vein contributing to mural isch-
emia.27 In addition, the hemodynamics of RA blood flow
in children and adolescents may favor graft enlargement.
Compared with the older adult, renovascular resistance in
the child is very low. In the presence of low resistance, the
hemodynamics of flow in the RA resembles an arterio-
venous communication. These characteristics of renal flow
in children may account for vein graft enlargement and
occasional aneurysm formation—changes reported in vir-
tually all large surgical series.
Presuming a flow-dependent change in vein grafts
among children, we selected saphenous vein conduits for
segmental branch repair to less than the entire kidney.
Whether this strategy will prove protective is unproven by
this experience. Among the seven saphenous vein repairs in
this series, enlargement of a vein graft has occurred in one
patient. However, follow-up angiographic and RDS studies
have revealed no mural thrombosis or aneurysmal degen-
Table IV. Comparison of the current series with a
coauthor’s previously published experience
Lawson/Dean4 Present study
1962-1977 1987-2004
No. of patients 25 25
Age range 2 mon-19 yrs 18 mon-21 yrs
Gender (M:F) 12:13 13:12
RA disease (%)
Hypoplasia 8 20
FMD/Dysplasia 64 44
MAS 8 12
Aneurysm 0 12
Dissection 0 8
Arteritis 0 4
RA trauma 8 0
Post-irradiation RA stenosis 4 0
Chronic pyelonephritis 8 0
Repair (%)
Unilateral 88 76
Bilateral 12 24
Ex vivo NS 13
Primary nephrectomy (%) 43 3
Primary & secondary nephrectomy (%) 54 6
Renal insufficiency (%)
SCr 1.3 mg/dL NS 16
Graft failure (%) 19 6
Hypertension response (%)
Cured 68 36
Improved 24 56
Failed 8 8
RA,Renal artery; FMD, fibromuscular dysplasia;MAS, midaortic syndrome;
SCr, serum creatinine; NS, not stated.eration.This report and others includes patients with subisthmic
aortic coarctation—the midaortic syndrome.17,18,22,26,28 In
this series, these coarctations lacked any evidence of inflam-
matory change or other injury and were presumed to reflect
failures of development. The associated visceral and RA le-
sions were ostial in location and were considered developmen-
tal or hypoplastic.
Despite many similarities, the extent of aortic involve-
ment and the subsequent surgical reconstruction in these
cases varied considerably. In one instance, the aorta from
the left subclavian artery to the abdominal aortic bifurca-
tion was hypoplastic, one demonstrated total abdominal
aortic hypoplasia, and one had only inter-renal aortic co-
arctation. One patient required thoracoabdominal aor-
toaortic bypass, with reimplantation of two left RAs. Total
abdominal aortic hypoplasia was treated by thoracoab-
dominal-to-bilateral common iliac bypass with reimplanta-
tion of two left RAs and PTFE bypass to the right. Inter-
renal coarctation was treated by PTFE patch aortoplasty,
with right RA reimplantation and left RA angioplasty.
Although concomitant visceral artery stenosis in com-
bination with midaortic syndrome is rarely symptomatic,
one child in this series with postprandial abdominal symp-
toms underwent simultaneous antegrade aortovisceral by-
pass. This patient was relieved of postprandial abdominal
pain after operation.
Children require patency of RA repair that may extend
60 years. The short course and high flow of direct aorto-
renal reconstruction favor their patency. Consequently,
flawless surgical technique is essential for lifelong success.
In the first half of this experience, aortography was
obtained 5 to 7 days after operation to assess the recon-
struction. This approach presumed that the first few days
after repair represented the optimal time for revision of
major defects. In the last half, intraoperative RDS scanning
was used to assess the adequacy of repair.29 In this instance,
major defects were revised at the first procedure. Overall,
three major defects were identified by completion RDS
scans and each was repaired.
The designation of lesion type deserves special com-
ment. In cases of ostial and branch RA stenosis, tissue for
histologic examination was not always available. In the past,
many of these RA lesions in childhood were designated as
fibromuscular dysplasia. In reality, however, many probably
reflect developmental or hypoplastic lesions (Fig 1, A and
B). These developmental lesions reflect failure of develop-
ment of all three layers of the vessel wall, providing an
“hourglass” appearance on gross inspection (Fig 1,  B).
Although the arrest in development may have its origin in
utero, the clinical manifestation of RA hypoplasia is not
realized until the adjacent arterial segments grow. In this
way, failures of in utero RA development may present at
birth or in later life.
Consideration of lesion type has particular importance
when percutaneous balloon dilatation (PTA) of childhood
lesions is considered. The role of PTA for RA lesions in the
pediatric population has yet to be defined. Technical suc-
cess and beneficial blood pressure response after PTA is
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amenable to PTA, however, appear to be limited. Hypo-
plastic lesions that represent failure of development are
likely to fail because of recoil.26 Although short-term suc-
cess with PTA has been reported for RA stenoses secondary
to arteritis and dysplasia, midaortic syndrome and hypo-
plastic lesions are unlikely to yield satisfactory results.16,26
Table IV compares the current series with a coauthor’s
previously published experience. Considered individually
and collectively, renovascular hypertension demonstrated
no gender predilection in children. Both series provided
equally diverse RA lesions contributing to hypertension;
however, there was a striking difference in the use of
nephrectomy. In the earlier series, 43% of lesions were
treated with total or partial primary nephrectomy compared
with 3% in the current report. This difference may be
explained by the current management strategy that empha-
sized RA reconstruction regardless of branch involvement.
Although this strategy required cold perfusion preservation
in half of cases, this approach recognized the risk of con-
tralateral renovascular disease over time. In this latter re-
gard, 14% of children from the earlier series demonstrated
contralateral RA lesions and hypertension on follow-up.
The rate of hypertension cure in the current series is
lower than the cure rates reported by most surgical series
summarized in Table V. Among peer-reviewed surgical
series reporting10 patients, the cure rate was 36% to 90%.
However, half of these reports failed to define hyperten-
sion, only half used gender and age criteria for hyperten-
sion, and no previous reports accounted for height. Blood
pressure response in many of these cases was likely ex-
pressed in terms of adult pressures rather than blood pres-
sures appropriate to children. Moreover, among children in
this series improved but not cured, 7% demonstrated seg-
mental renal infarction at surgery, and 14% are awaiting
contralateral RA repair. Finally, the strategy of routine
revascularization resulted in a high rate of renal salvage;
however, this strategy may have also contributed to uncor-
rected intrarenal lesions that other authors would have
Table V. Open surgical repair for renal artery disease in ch
Location N Years % Revasc
Clichy, France31 78 1975-98 86
Ann Arbor, Mich26 57 1963-93 81
Cleveland, Ohio21 56 1955-88 79
Nashville, Tenn &
Philadelphia, Pa17
53 NS 76
Nashville, Tenn4 25 1962-77 46
Cincinnati, Ohio32 14 1966-86 86
San Francisco, Calif33 14 1960-74 71
Buenos Aires, Argentina28 15 NS 87
Total 312 78
Revasc, Revascularized; Neph, nephrectomy; NS, not stated.
*Total or partial nephrectomy; primary or secondary procedure.
†Total does not include French study.treated with nephrectomy.This is the first series to examine change in GFR after
renal revascularization in children. The mean calculated
GFR increased by 23% compared to preoperative values. It
should be noted, however, that patient heights at the time
of last serum creatinine measurement were unavailable.
Therefore, heights were estimated from the patient’s per-
centile for height at presentation and adjusted using age at
the time of last serum creatinine measurement. Despite this
potential limitation of these data, no patient progressed to
hemodialysis during follow-up.
In conclusion, the RA lesions contributing to severe
hypertension in children and adolescents are heteroge-
neous and frequently complex. RA repair and kidney sal-
vage in these young patients is preferred over nephrectomy
but requires branch RA repair in most and cold perfusion
preservation in half. Beneficial blood pressure response and
long-term patency of repair can be achieved in greater than
90% of cases.
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Dr Robert Smith III (Atlanta, Ga). Dr Piercy and his
colleagues should be congratulated for their exemplary clinical
results in a challenging group of 25 young patients with reno-
vascular disease. They achieved beneficial blood pressure re-
sponses in 92% with no operative mortality, only one unplanned
nephrectomy and 91% primary renal artery patency at 33
months. All patients underwent open surgical revascularizations
and none had balloon angioplasty as primary therapy. Mean age
at operation was 11.6 years. Only one patient was operated
under age 5. I have several questions concerning clinical features
and one that is more health care systems oriented.
Your preferred conduit for renal artery bypass in children and
adolescents is the hypogastric artery autograft. Would you harvest
both hypogastric arteries in a young male patient?
Patients with renal artery hypoplasia may also have severe
coexisting visceral artery stenoses, as you indicated, with or with-
out related symptoms. Do you recommend simultaneous renal and
mesenteric artery reconstructions in these children with multiple
vessels affected?
Sixteen percent of your patients had preoperative renal insuf-
ficiency. What were the renal function outcomes in this subset?
Finally, Wake Forest, a recognized regional referral center for
renal artery disease, took 17 years to accumulate this series of 25
patients under age 21, or roughly only 1 to 2 new patients per year.
This would suggest that pediatric renovascular disease might best
be managed in centers of excellence rather than by individual
vascular surgeons seeing only an occasional case. What is your
advice in this regard?
Dr K. Todd Piercy (Winston-Salem, NC). Thank you for
your kind comments, Dr Smith, and for your excellent questions. IFirst of all, in terms of using bilateral hypogastric arteries, we
have not had to do that in any of our patients thus far and we would
be hesitant to do so in a male at any age.
Secondly, in terms of mesenteric lesions, if we have a patient
who is asymptomatic and we see a lesion on arteriography, we do
not currently undertake a mesenteric artery repair at the initial
operation. We did have one patient who presented with a mid-
aortic syndrome who was also noted to have lesions of both the
superior mesenteric and the celiac arteries. This patient was symp-
tomatic with a complaint of postprandial pain. She underwent
renal and superior mesenteric artery repair at the same operative
setting and her symptoms did resolve. This is the only case in which
we have performed concurrent renal and mesenteric revasculariza-
tion.
In terms of our renal insufficiency outcomes, when we looked
at postoperative calculated GFRs one problem encountered was
that we did not have their postoperative weights at their final
follow-up. Therefore, we used the patient’s preoperative percentile
for weight to predict their follow-up weight for renal function
calculation. Surprisingly we did find a significant improvement in
the GFRs at follow-up. The mean GFR preoperatively was 82
ml/min/1.73m2 and 98.2 ml/min/1.73m2 at follow-up with a p
value of0.05. Given the fact that this was an estimation using the
estimates of weight and height at the second follow-up these
findings are to be taken cautiously.
Finally, addressing as to whom should perform such cases on
children, we agree that the pediatric renovascular disease should be
treated by institutions having experience in such cases rather than
by those rarely seeing this entity.
Dr John Hallett (Charleston, SC). While I was at the Mayo
Clinic, a few issues came up when we saw these patients and I’d be
JOURNAL OF VASCULAR SURGERY
June 2005982 Piercy et alinterested in your comment. One is the staging, because many of
these children present when they are in their younger years and you
mentioned that you didn’t do any before age 5. Do you try to bring
children along until they reach a certain size or age before doing
this? The second issue that we saw frequently was the interest in
balloon angioplasty, either by referring physician or by families
when they came to us. Can you comment on balloon angioplasty
either in your own practice or in patients referred to you? The final
question is what is the one drug or the most common drug that
you have found effective if you have to keep the kids on some
medication?
Dr Piercy. In terms of our age of repair, we did have one child
that was repaired at 18 months. Typically we try to bring the kids
along until they are age 5 or 6 which allows time for their renal
arteries and kidneys to approach a normal adult size before repair.
The child that we repaired at 18 months had severe hypertension
that was uncontrollable on medication so we had to act.
In terms of balloon angioplasty at our institution currently we
take no effort in performing balloon angioplasty in the pediatric
population. In the literature there have been reports of some
success rates similar to what we have had in terms of patency rates
and hypertension response; however, I caution the use of balloon
angioplasty in such lesions because lesions presumed to be dysplas-
tic may actually represent hypoplastic lesions. It is unlikely that
hypoplastic lesions are amenable to balloon angioplasty due to
recoil. Also, among patients with mid-aortic syndrome balloon
angioplasty probably has no benefit. Lesions reported in the liter-
ature to have had success with balloon angioplasty have beenarteritis and confirmed dysplasias. In terms of drug therapy, the
nephrologists typically treat our patients currently with medica-
tions and most have been on beta blockers and ace inhibitors at the
time of presentation.
Dr (inaudible). I have one simple question and that is, why
weren’t all the children cured of their high blood pressure. We
always have this sort of nagging tail of patients that were
improved. Now in children with a defined lesion and presum-
ably of acute onset, do they have fibrosis in their kidney? What
is the reason that some of them continue to require antihyper-
tensive medication when fix the problem?
Dr Piercy. We have the same question. In the literature
cure rates range anywhere from our 36 to 40% up to 90%. We
think part of this may be due to other underlying co-morbidi-
ties. We investigated body mass index, although it did not reach
statistical significance we found that more patients in the im-
proved and failed groups than among the cured group had BMIs
of 25 or greater indicating morbid obesity which may play a
factor in continued hypertension. Also, earlier reports with
better cure rates tended to use nephrectomy more often than in
our study. We hypothesize that there may be distal vessel disease
in some patients that we missed on arteriography that remains a
critical stenosis after more proximal revascularization which
would have been taken care of with nephrectomy and this may
result in continued hypertension. Another failure that we had
was among a 21 year old who we feel may have had some renal
tubular disease from his longstanding hypertension that was not
affected by revascularization.
